GlassScriptPhysician profile
Amanda Szymanski
NPI 1669889176
$855.22
in general payments reported to CMS, 2019-2025
15 companies · $261 in 2025
The $261 reported for 2025 was more than what 86% of Pediatrics (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $90.40).
See the full distribution for Pediatrics (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.32 · 2022: $27.65 · 2023: $44.73 · 2024: $508 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $197.27 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $172.20 | 2024 | |
| Sanofi-Aventis U.S. LLC | $65.72 | 2024-2025 | |
| Cranial Technologies, INC | $64.06 | 2022-2024 | Doc Band |
| Collegium Pharmaceutical, INC. | $52.24 | 2025 | Jornay Pm |
| Seqirus USA INC | $49.31 | 2024 | Flucelvax |
| Sanofi Pasteur INC. | $45.34 | 2025 | |
| Glaxosmithkline, LLC. | $41.53 | 2024 | Bexsero, Rotarix |
| Pfizer INC. | $40.17 | 2023-2024 | |
| Novo Nordisk INC | $38.41 | 2025 | Wegovy |
| Ars Pharmaceuticals Operations, INC. | $24.20 | 2025 | Neffy |
| Lnhc, INC | $20.51 | 2025 | Zelsuvmi |
| Kaleo, INC. | $16.00 | 2024 | Auvi-Q |
| Tris Pharma INC | $14.94 | 2025 | Quillivant |
| Abbvie INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Szymanski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.